UK cardiovascular devices market is estimated to grow significantly at a CAGR of 5.0% during the forecast period. This growth is backed by the presence of advanced healthcare infrastructure and continuous rise in the prevalence of CVD in the country. UK has the significant number of CVD, CHD, Stroke, heart failure, atrial fibrillation, and other heart patients. According to the British Heart Foundation (BHF), more than 7 million people living with the CVD and about 152,465 mortalities due to CVD. The critical factors that are leading to CVD, CHD, Stroke and another heart disease such as harmful stress, depression, excessive consumption of alcohol, excessive smoking, hypertension, diabetes, obesity and poor diet which includes cholesterol.
Visit for Global Cardiovascular Devices Market Report at: https://www.omrglobal.com/industry-reports/cardiovascular-devices-market
UK cardiovascular devices market is bifurcated on the basis of type of devices into diagnostic and monitoring devices and surgical devices. The cardiovascular devices market based on diagnostic and monitoring devices is further segmented into MRI, electrocardiogram (ECG), remote cardiac monitoring, cardiac CT, and others. ECG drives the global cardiovascular diagnostics and monitoring devices market. The ECG is widely recommended to the CVD patients in order to keep a track of the disease. Moreover, the integration of advanced technologies, such as AI, in ECG will further augment the market growth during the forecast period. Whereas the cardiovascular devices market based on surgical devices is further segmented into stents, catheters, cardiac assist devices, cardiac rhythm management device, and others. The stents contribute significantly in the cardiovascular surgical devices market.
The companies which are contributing to the growth of the UK cardiovascular devices market include Abbott Laboratories, Boston Scientific Corp., Edwards Lifesciences Corp., Medtronic PLC, Terumo Corp., Becton, Dickinson and Co., Getinge AB, VitalConnect, Inc., and Johnson & Johnson Services, Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market.
Research Methodology
The market study of the UK cardiovascular devices market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report provides an in-depth analysis of market size, various services offered by the players, and market opportunity. The report will serve as a source for 360-degree analysis of the market delivering insights for making better business decisions.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. UK Cardiovascular Devices Market by Type
5.1.1. Diagnostic and Monitoring Devices
5.1.1.1. MRI
5.1.1.2. Electrocardiogram (ECG)
5.1.1.3. Remote Cardiac Monitoring
5.1.1.4. Cardiac CT
5.1.1.5. Others (PET scan)
5.1.2. Surgical Devices
5.1.2.1. Stents
5.1.2.2. Catheters
5.1.2.3. Cardiac Assist Devices
5.1.2.4. Cardiac Rhythm Management Device
5.1.2.5. Others (Heart Valves and Grafts)
6. Company Profiles
6.1. Abbott Laboratories
6.2. B. Braun Melsungen AG
6.3. Becton, Dickinson and Co.
6.4. Boston Scientific Corp.
6.5. Edwards Lifesciences Corp.
6.6. GE Healthcare (General Electric Co.)
6.7. Johnson & Johnson Services, Inc.
6.8. Koninklijke Philips N.V.
6.9. Medtronic PLC
6.10. Siemens AG
6.11. Smith & Nephew PLC
6.12. Stryker Corp.
6.13. Terumo Corp.
1. UK CARDIOVASCULAR DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
1. UK CARDIOVASCULAR DEVICES MARKET SIZE, 2019-2026 ($ MILLION)
2. UK CARDIOVASCULAR DEVICES MARKET SHARE BY TYPE, 2019 VS 2026 (%)